BEAM
Price
$29.03
Change
-$0.38 (-1.29%)
Updated
Jun 12 closing price
Capitalization
2.99B
58 days until earnings call
Intraday BUY SELL Signals
MAZE
Price
$24.05
Change
-$0.04 (-0.17%)
Updated
Jun 12 closing price
Capitalization
1.33B
65 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs MAZE

Header iconBEAM vs MAZE Comparison
Open Charts BEAM vs MAZEBanner chart's image
BEAM vs MAZE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BEAM vs. MAZE commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and MAZE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2026
Stock price -- (BEAM: $29.03 vs. MAZE: $24.05)
Brand notoriety: BEAM and MAZE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 77% vs. MAZE: 90%
Market capitalization -- BEAM: $2.99B vs. MAZE: $1.33B
BEAM [@Biotechnology] is valued at $2.99B. MAZE’s [@Biotechnology] market capitalization is $1.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $112.92B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileMAZE’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • MAZE’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than MAZE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while MAZE’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 4 bearish.
  • MAZE’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MAZE is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -1.26% price change this week, while MAZE (@Biotechnology) price change was -0.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.78%. For the same industry, the average monthly price growth was +90.18%, and the average quarterly price growth was +2050.65%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 11, 2026.

MAZE is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (+0.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.99B) has a higher market cap than MAZE($1.33B). BEAM YTD gains are higher at: 4.726 vs. MAZE (-41.950). MAZE has higher annual earnings (EBITDA): -131.29M vs. BEAM (-349.25M). BEAM has more cash in the bank: 1.21B vs. MAZE (352M). MAZE has less debt than BEAM: MAZE (61.2M) vs BEAM (251M). BEAM has higher revenues than MAZE: BEAM (164M) vs MAZE (20M).
BEAMMAZEBEAM / MAZE
Capitalization2.99B1.33B224%
EBITDA-349.25M-131.29M266%
Gain YTD4.726-41.950-11%
P/E RatioN/A191.34-
Revenue164M20M820%
Total Cash1.21B352M344%
Total Debt251M61.2M410%
FUNDAMENTALS RATINGS
BEAM: Fundamental Ratings
BEAM
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMMAZE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
76%
Bullish Trend 11 days ago
90%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
67%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
MAZE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEDIX23.150.31
+1.36%
Fidelity Advisor Emerg Mkts Discv I
VSFRX28.180.33
+1.18%
Federated Hermes MDT Small Cap Value R
AGFGX12.440.05
+0.40%
American Century Focused Global Gr R5
RGAEX84.550.23
+0.27%
American Funds Growth Fund of Amer R4
JCNRX29.47N/A
N/A
Janus Henderson Contrarian R

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-1.29%
CRSP - BEAM
71%
Closely correlated
-0.86%
EDIT - BEAM
61%
Loosely correlated
+2.46%
PRME - BEAM
61%
Loosely correlated
-1.60%
NTLA - BEAM
59%
Loosely correlated
-1.94%
AXON - BEAM
57%
Loosely correlated
-1.00%
More

MAZE and

Correlation & Price change

A.I.dvisor indicates that over the last year, MAZE has been loosely correlated with AVXL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MAZE jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAZE
1D Price
Change %
MAZE100%
-0.17%
AVXL - MAZE
38%
Loosely correlated
N/A
PROK - MAZE
37%
Loosely correlated
-1.20%
IMNM - MAZE
34%
Loosely correlated
+0.11%
ADMA - MAZE
31%
Poorly correlated
-1.32%
BEAM - MAZE
29%
Poorly correlated
-1.29%
More